Cyteir Therapeutics Stock Short Ratio
CYTDelisted Stock | USD 2.76 0.01 0.36% |
Cyteir Therapeutics fundamentals help investors to digest information that contributes to Cyteir Therapeutics' financial success or failures. It also enables traders to predict the movement of Cyteir Stock. The fundamental analysis module provides a way to measure Cyteir Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cyteir Therapeutics stock.
Cyteir |
Cyteir Therapeutics Company Short Ratio Analysis
Cyteir Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Cyteir Therapeutics Short Ratio | 3.07 X |
Most of Cyteir Therapeutics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyteir Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, Cyteir Therapeutics has a Short Ratio of 3.07 times. This is 21.28% lower than that of the Biotechnology sector and 58.57% lower than that of the Health Care industry. The short ratio for all United States stocks is 23.25% higher than that of the company.
Cyteir Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cyteir Therapeutics' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cyteir Therapeutics could also be used in its relative valuation, which is a method of valuing Cyteir Therapeutics by comparing valuation metrics of similar companies.Cyteir Therapeutics is currently under evaluation in short ratio category among its peers.
Cyteir Fundamentals
Return On Equity | -0.24 | |||
Return On Asset | -0.14 | |||
Current Valuation | (20.89 M) | |||
Shares Outstanding | 36 M | |||
Shares Owned By Insiders | 6.63 % | |||
Shares Owned By Institutions | 76.83 % | |||
Number Of Shares Shorted | 319.73 K | |||
Price To Earning | 0.36 X | |||
Price To Book | 0.87 X | |||
Gross Profit | (16.59 M) | |||
EBITDA | (33.41 M) | |||
Net Income | (33.22 M) | |||
Cash And Equivalents | 166.4 M | |||
Cash Per Share | 4.71 X | |||
Total Debt | 889 K | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 19.95 X | |||
Book Value Per Share | 3.47 X | |||
Cash Flow From Operations | (25.79 M) | |||
Short Ratio | 3.07 X | |||
Earnings Per Share | (0.93) X | |||
Price To Earnings To Growth | (0.03) X | |||
Target Price | 3.0 | |||
Number Of Employees | 46 | |||
Beta | 0.096 | |||
Market Capitalization | 108.71 M | |||
Total Asset | 153.23 M | |||
Retained Earnings | (138.11 M) | |||
Working Capital | 143.89 M | |||
Current Asset | 834.8 M | |||
Current Liabilities | 366.9 M | |||
Net Asset | 153.23 M |
About Cyteir Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cyteir Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cyteir Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cyteir Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Cyteir Stock
If you are still planning to invest in Cyteir Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyteir Therapeutics' history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |